Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Neurobiol ; 55(10): 7921-7940, 2018 Oct.
Article in English | MEDLINE | ID: mdl-29488136

ABSTRACT

Imbalances between excitatory and inhibitory synaptic transmission cause brain network dysfunction and are central to the pathogenesis of neurodevelopmental disorders. Parvalbumin interneurons are highly implicated in this imbalance. Here, we probed the social behavior and hippocampal function of mice carrying a haploinsufficiency for Ambra1, a pro-autophagic gene crucial for brain development. We show that heterozygous Ambra1 mice (Ambra+/-) are characterized by loss of hippocampal parvalbumin interneurons, decreases in the inhibition/excitation ratio, and altered social behaviors that are solely restricted to the female gender. Loss of parvalbumin interneurons in Ambra1+/- females is further linked to reductions of the inhibitory drive onto principal neurons and alterations in network oscillatory activity, CA1 synaptic plasticity, and pyramidal neuron spine density. Parvalbumin interneuron loss is underlined by increased apoptosis during the embryonic development of progenitor neurons in the medial ganglionic eminence. Together, these findings identify an Ambra1-dependent mechanism that drives inhibition/excitation imbalance in the hippocampus, contributing to abnormal brain activity reminiscent of neurodevelopmental disorders.


Subject(s)
Adaptor Proteins, Signal Transducing/metabolism , Hippocampus/pathology , Hippocampus/physiopathology , Neural Inhibition , Neurodevelopmental Disorders/metabolism , Neurodevelopmental Disorders/physiopathology , Animals , Apoptosis , Behavior, Animal , Embryo, Mammalian/metabolism , Embryo, Mammalian/pathology , Female , Gamma Rhythm , Interneurons/metabolism , Male , Mice, Inbred C57BL , Neurodevelopmental Disorders/pathology , Neuronal Plasticity , Parvalbumins/metabolism , Social Behavior
2.
Nat Commun ; 8: 14727, 2017 04 03.
Article in English | MEDLINE | ID: mdl-28367951

ABSTRACT

Alterations of the dopaminergic (DAergic) system are frequently reported in Alzheimer's disease (AD) patients and are commonly linked to cognitive and non-cognitive symptoms. However, the cause of DAergic system dysfunction in AD remains to be elucidated. We investigated alterations of the midbrain DAergic system in the Tg2576 mouse model of AD, overexpressing a mutated human amyloid precursor protein (APPswe). Here, we found an age-dependent DAergic neuron loss in the ventral tegmental area (VTA) at pre-plaque stages, although substantia nigra pars compacta (SNpc) DAergic neurons were intact. The selective VTA DAergic neuron degeneration results in lower DA outflow in the hippocampus and nucleus accumbens (NAc) shell. The progression of DAergic cell death correlates with impairments in CA1 synaptic plasticity, memory performance and food reward processing. We conclude that in this mouse model of AD, degeneration of VTA DAergic neurons at pre-plaque stages contributes to memory deficits and dysfunction of reward processing.


Subject(s)
Alzheimer Disease/pathology , Alzheimer Disease/physiopathology , Dopaminergic Neurons/pathology , Memory , Reward , Alzheimer Disease/complications , Alzheimer Disease/drug therapy , Animals , Apoptosis/drug effects , Cell Death/drug effects , Dendritic Spines/metabolism , Dihydroxyphenylalanine/pharmacology , Dihydroxyphenylalanine/therapeutic use , Disease Models, Animal , Dopaminergic Neurons/drug effects , Dopaminergic Neurons/metabolism , Food , Hippocampus/drug effects , Hippocampus/pathology , Hippocampus/physiopathology , Inflammation/complications , Inflammation/pathology , Mice, Transgenic , Nerve Degeneration/complications , Nerve Degeneration/drug therapy , Nerve Degeneration/pathology , Neuronal Plasticity/drug effects , Nucleus Accumbens/pathology , Nucleus Accumbens/physiopathology , Plaque, Amyloid/complications , Plaque, Amyloid/pathology , Plaque, Amyloid/physiopathology , Selegiline/pharmacology , Selegiline/therapeutic use , Ventral Tegmental Area/drug effects , Ventral Tegmental Area/pathology , Ventral Tegmental Area/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...